CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 4 Grant or award Director acquired 635 shares (grant or award)
- 4 Grant or award Director acquired 1,271 shares (grant or award)
- 4 Open-market sale President & CEO sold 100,000 shares at $10.38 ($1,038,000)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Grant or award Chief Legal Officer acquired 34,000 shares (grant or award)
- 4 Grant or award Chief R&D Officer acquired 81,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 127,500 shares (grant or award)
- 4 Grant or award Exec. Director, Finance - PAO acquired 5,900 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 34,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 34,000 shares (grant or award)
- 4 Open-market sale President & CEO sold 14,100 shares at $10.90 ($153,690)
- 4 Open-market sale Chief R&D Officer sold 3,125 shares at $10.89 ($34,031)
- 4 Open-market sale Chief Financial Officer sold 5,700 shares at $10.90 ($62,130)
- 4 Open-market sale Chief Commercial Officer sold 6,100 shares at $10.90 ($66,490)
- 4 Open-market sale Exec. Director, Finance - PAO sold 445 shares at $10.90 ($4,851)
- 4 Open-market sale Chief Legal Officer sold 4,175 shares at $10.88 ($45,424)
- 4 Open-market sale Exec. Director, Finance - PAO sold 8,600 shares at $13.01 ($111,886)
- 4 Open-market sale President & CEO sold 297,573 shares at an average $12.94 ($3,851,918)
- 4 Grant or award Director acquired 421 shares (grant or award)
- 4 Grant or award Director acquired 421 shares (grant or award)
Page 8 of 49 · 965 filings